Anti-Human PCSK9 Recombinant Antibody(Ralpancizumab)
-
产品编号
YR1326
-
别名
科研级 Ralpancizumab ( 雷泮赛珠单抗 ), Anti-PCSK9 Recombinant Antibody, Research Grade Ralpancizumab
-
规格
- 1mg
- 5mg
| Catalog Number | YR1326 |
| Alias | 科研级 Ralpancizumab ( 雷泮赛珠单抗 ), Anti-PCSK9 Recombinant Antibody, Research Grade Ralpancizumab |
| Size | 1mg, 5mg |
| Molecular Name | Ralpancizumab |
| CAS Number | 1407495-04-8 |
| Target | PCSK9[Homo sapiens] |
| Host | Mouse |
| Antibody Isotype | IgG2 Kappa |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Ralpancizumab (INN, development code RN317) is a monoclonal antibody designed for the treatment of dyslipidemia. |
| Application | Neut, ELISA, IF, IP, FuncS, FCM, ICC |
| Remarks | This product is for research use only. |
0